S'abonner

Does simulation improve clinical performance in management of postpartum hemorrhage? - 01/10/21

Doi : 10.1016/j.ajog.2021.05.025 
Shena J. Dillon, MD , Whitney Kleinmann, MD, Yevgenia Fomina, MD, Bethany Werner, MD, Steven Schultz, PharmD, MBA, Shannon Klucsarits, MD, Wilmer Moreno, MD, Alexandra Butsko, BSN, RN, RNC-OB, Donald D. McIntire, PhD, David B. Nelson, MD
 Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 

Corresponding author: Shena J. Dillon, MD.

Abstract

Background

Although simulation is now widely used to improve teamwork and communication, data demonstrating improvement in clinical outcomes are limited.

Objective

This study aimed to examine the clinical performance and outcomes associated with postpartum hemorrhage because of uterine atony following the implementation of a multidisciplinary simulation program.

Study Design

This was a prospective observational study of response to postpartum hemorrhage because of uterine atony in an academic medical center before (epoch 1: July 2017–June 2018) and after (epoch 2: July 2019–June 2020) implementing a multidisciplinary simulation program. A total of 22 postpartum hemorrhage simulations were performed from July 2018 to June 2019 involving more than 300 nursing, obstetrical, and anesthesia providers. The simulation program focused on managing postpartum hemorrhage events and improving teamwork and communication of the multidisciplinary teams. To evaluate the clinical effectiveness of the simulation program, the primary outcome was response to postpartum hemorrhage defined as the time from the administration of uterotonic medications to transfusion of the first unit of blood in the first 12 hours following delivery, comparing epoch 2 to epoch 1 following the implementation of a simulation program. Statistical analysis included the use of the Pearson chi-square test, Wilcoxon rank-sum test, Hodges-Lehmann statistic for differences, and bootstrap methods with a P value of <.05 considered significant.

Results

Between July 1, 2017, and June 30, 2018, there were 12,305 patients who delivered, of which 495 patients (4%) required transfusion. Between July 1, 2019, and June 30, 2020, there were 12,414 patients who delivered, of which 480 patients (4%) required transfusion. When isolating cases of postpartum hemorrhage because of uterine atony in both transfused groups, there were 157 women in the presimulation group (epoch 1) and 165 women in the postsimulation group (epoch 2), respectively. There was no difference in age, race, parity, or perinatal outcomes between the 2 epochs. Women in epoch 2 began receiving blood products significantly earlier in the first 12 hours following delivery compared with women in epoch 1 (51 [range, 28–125] minutes vs 102 [range, 32–320] minutes; P=.005). In addition, there was a significantly decreased variation in the time from the administration of uterotonic medications to transfusion of blood in epoch 2 (P=.035). Furthermore, women in epoch 2 had significantly lower estimated blood loss than women in epoch 1 (1250 [range, 1000–1750] mL vs 1500 [range, 1000–2000] mL; P=.032).

Conclusion

The implementation of a multidisciplinary simulation program at a large academic center focusing on the management of postpartum hemorrhage was associated with an improved clinical response. Specifically, there were significantly faster times from the administration of uterotonic medications to transfusion of blood, decreased variance in the time from the administration of uterotonic medications to transfusion of blood, and lower estimated blood loss following the implementation of a simulation program. Because delay in treatment is a major cause of preventable maternal death in obstetrical hemorrhage, the results in our study provided clinical evidence that a simulation program may improve patient outcomes in such emergencies.

Le texte complet de cet article est disponible en PDF.

Key words : blood loss, clinical outcomes, estimated blood loss, multidisciplinary, postpartum hemorrhage, pregnancy, simulation, transfusion, uterotonic


Plan


 The authors report no conflict of interest.
 Cite this article as: Dillon SJ, Kleinmann W, Fomina Y, et al. Does simulation improve clinical performance in management of postpartum hemorrhage? Am J Obstet Gynecol 2021;225:435.e1-8.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 225 - N° 4

P. 435.e1-435.e8 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • October 2019 (vol. 221, no. 4, page 374)
| Article suivant Article suivant
  • The impact of physical activity during pregnancy on labor and delivery
  • Virginia Y. Watkins, Carly M. O’Donnell, Marta Perez, Peinan Zhao, Sarah England, Ebony B. Carter, Jeannie C. Kelly, Antonina Frolova, Nandini Raghuraman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.